Alexander Burges

Department of Obstetrics and Gynecology

University Hospital, Ludwig-Maximilian-University (LMU) Munich

BIOGRAPHY

Alexander Burges has not added Biography.

If you are Alexander Burges and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2007 | Pubmed ID: 17606723

Ovarian cancer: diagnosis and treatment.

Deutsches Arzteblatt international Sep, 2011 | Pubmed ID: 22025930

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients.

International journal of molecular sciences Dec, 2018 | Pubmed ID: 30597961

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.

International journal of molecular sciences Jun, 2019 | Pubmed ID: 31212758

M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis.

Cells May, 2020 | Pubmed ID: 32429133

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.

Histochemistry and cell biology Oct, 2020 | Pubmed ID: 32572587

β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation.

Frontiers in endocrinology , 2020 | Pubmed ID: 33042017

Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer.

Translational oncology Jan, 2021 | Pubmed ID: 33069100

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway.

Biomedicines Jun, 2021 | Pubmed ID: 34206491

The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.

Cells Sep, 2021 | Pubmed ID: 34571986

Risk of postpartum depressive symptoms is influenced by psychological burden related to the COVID-19 pandemic and dependent of individual stress coping.

Archives of gynecology and obstetrics Dec, 2023 | Pubmed ID: 36482113

PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.

International journal of molecular sciences Jan, 2023 | Pubmed ID: 36614323

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.

Journal of cancer research and clinical oncology Sep, 2023 | Pubmed ID: 37131060

INSTITUTIONS

University Hospital, Ludwig-Maximilian-University (LMU) Munich

JOVE ARTICLES

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Fabian Trillsch^*,1,2,

Juliane Reichenbach^*,1,

Bastian Czogalla¹,

Fabian Kraus¹,

Alexander Burges¹,

Sven Mahner^1,2,

Mirjana Kessler^1,2

¹Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilian-University (LMU) Munich,

², German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich

Cancer Research

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

Alexander Burges

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Obstetrics and Gynecology

University Hospital, Ludwig-Maximilian-University (LMU) Munich

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Department of Obstetrics and Gynecology